Financials
- Market Capitalization 2.48 B
- Employee 370
- Founded 2016
- CEO N/A
- Website www.tarsusrx.com
- Headquarter Delaware, United States
- FIGI BBG00RB9BNQ7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-63.2
市销率
5.56
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1850 | TRVI Trevi Therapeutics, Inc. - Common Stock | 18.15 USD | +1.34% | -2.37% | +23.72% | +164.58% | 2.58 B USD | ||
| 1867 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.87 USD | +3.87% | -1.81% | +40.99% | +112.93% | 2.48 B USD | ||
| 1871 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.79 USD | -4.48% | -7.05% | +68.29% | +566.15% | 2.38 B USD | ||
| 1875 | VCEL Vericel Corporation - Common Stock | 46.73 USD | +1.39% | -0.62% | +21.63% | +28.56% | 2.39 B USD |